Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
My statement on streamlining process for shared REMS; improving efficiency and increasing access to generic drugs https://t.co/LqV8ImfvE6
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: My statement on streamlining process for shared REMS; improving efficiency and increasing access to generic drugs https://t.co/LqV8ImfvE6
SteveFDA (R-D.C.)
@SGottliebFDA
RT @NicholasFlorko: Worth noting that two top FDA officials dealing w/ drug pricing (Fmr Chief Counsel Liz Dickinson & Deputy CoS Maari… https://t.co/xueGg2Yqxf
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: BioCentury: #FDA takes on anticompetative policy practices https://t.co/qSlY5gLyAd
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: FDA Commissioner @SGottliebFDA had a chance to talk with cancer survivors & advocates this morning at the… https://t.co/Z4J0K1ChET
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA action to address addictiveness of tobacco products vital to improving public health: new research via CDC, FDA https://t.co/WwxoGiTKD8
SteveFDA (R-D.C.)
@SGottliebFDA
RT @califf001: Important effort to improve pediatric therapeutics. https://t.co/te6j4inJ9X QT @US_FDA: Despite efforts to ↑ the number of FDA-approved therapies for children, 60% of drugs used in children are not appro… https://t.co/LA9E48cc4e)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA action to address addictiveness of tobacco products vital to improving public health: new research via CDC, FDA https://t.co/WwxoGiTKD8
SteveFDA (R-D.C.)
@SGottliebFDA
Want to learn more about cancer drug development? Register for #FDAs Nov. 13 workshop for cancer patient advocates… https://t.co/tg2XZ1X9uI
SteveFDA (R-D.C.)
@SGottliebFDA
Bloomberg: #FDA Broadens Generic Drug Competition Efforts, Pressuring Prices https://t.co/hzF4ta8p8D
SteveFDA (R-D.C.)
@SGottliebFDA
The #FDA honors the contributions of the men and women who have served our country. #VeteransDay2017 https://t.co/E0Vi2LFe1u
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Want to learn more about cancer drug development? Register for #FDAs Nov. 13 workshop for cancer patient advocates… https://t.co/tg2XZ1X9uI
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: To spur competition, access #FDA modernizes its guidelines for development of Hep C treatments in new, more efficie… https://t.co/lvQOVHjot0
SteveFDA (R-D.C.)
@SGottliebFDA
To spur competition, access #FDA modernizes its guidelines for development of Hep C treatments in new, more efficie… https://t.co/lvQOVHjot0
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA Broadens Generic Drug Competition Efforts, Pressuring Prices, With New Policy on How Agency Prioritizes Apps https://t.co/hzF4ta8p8D
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA welcomes new cancer patient advocates to FDA today for @FDAOncology’s Partners in Progress meeting: “effective… https://t.co/3UtEivVyFi
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Despite efforts to ↑ number of FDA-approved therapies for children, 60% of drugs used in children not approved for… https://t.co/or305ef1eu
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA welcomes new cancer patient advocates to FDA today for @FDAOncology’s Partners in Progress meeting: “effective… https://t.co/3UtEivVyFi
SteveFDA (R-D.C.)
@SGottliebFDA
Today is #FDAs first annual educational workshop for new cancer patient advocates - learn Agency basics and advocac… https://t.co/bOXer2nfqt
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Today is #FDAs first annual educational workshop for new cancer patient advocates - learn Agency basics and advocac… https://t.co/bOXer2nfqt